CRISPR Patent Fight Moves Ahead

Dec 31, 2015

This year may have been the CRISPR's breakout year as a technology, but the patent dispute over who owns the intellectual property for the tool is only getting underway. According to Jacob Sherkow at Stanford's Law and Biosciences Blog, a patent examiner has issued an Initial Interference Memo, paving the way for an interference proceeding.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Refined Risk Prediction

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

Shutdown and the FDA

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

This Week in PNAS

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

Influences from Here and There

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.

Main menu